FDA Adverse Event Injury Summary report: N

INRATIO PT/INR TEST STRIPS

MDR report key: 4101632 · Received August 27, 2014

Report

Report Number
2027969-2014-00791
Event Type
Injury
Date Received
August 27, 2014
Date of Event
August 6, 2014
Report Date
August 6, 2014
Manufacturer
ALERE SAN DIEGO, INC.
Product Code
GJS
PMA / PMN Number
K092987
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

INVESTIGATION PENDING.

Description of Event or Problem · 1

CALLER ALLEGED DISCREPANT LOW INRATIO INR RESULT IN COMPARISON TO AN ALTERNATE POINT OF CARE (POC) INR RESULT. RESULTS ARE AS FOLLOWS: DATE: (B)(6) 2014. INRATIO INR: 5.3 AND 5.1 (5 MINUTES APART), POC INR: 1.6 AND 1.5 (5 MINUTES APART). THERAPEUTIC RANGE: 2.0-3.0. THE PATIENT HELD HIS WARFARIN ON (B)(6) 2014 AS A RESULT OF THE INRATIO RESULTS. NO FURTHER TESTING (INRATIO OR LABORATORY) WAS PERFORMED UNTIL (B)(6) 2014 AT WHICH TIME A NEW INRATIO STRIP LOT SHOWED INR OF 3.1. THE PATIENT WAS SATISFIED WITH THE RESULT. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
522815 INRATIO PT/INR TEST STRIPS PROTHROMBIN TIME TEST GJS ALERE SAN DIEGO, INC. 100071 332829

Patients

Seq Age Sex Outcome Treatment
1 Other INRATIO MONITOR SN: (B)(4)| WARFARIN 7.5MG